Form 4: Labcorp Director Wengel Converts RSUs to Common Stock

Sentiment:

Insider Transaction Report


Labcorp Holdings Inc. Director Kathryn E. Wengel converted 897 Restricted Stock Units into common stock on February 11, 2026.

Summary

  • Kathryn E. Wengel, a Director of Labcorp Holdings Inc. (LH), reported a change in beneficial ownership.
  • On February 11, 2026, 897 Restricted Stock Units (RSUs) vested fully and were subsequently converted into 897 shares of Labcorp Common Stock.
  • Following this transaction, Wengel directly owns 4,133 shares of Common Stock and continues to hold 773 Restricted Stock Units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine compensation-related transaction for a director, with no direct positive or negative implications for the company's operational or financial performance.

Positives

  • A director continues to hold a significant number of shares and RSUs, aligning their interests with shareholders.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that such insider transactions, particularly the vesting and conversion of equity awards like Restricted Stock Units, are routine events in publicly traded companies across all industries. They represent a standard component of executive and director compensation packages, designed to align management interests with long-term shareholder value.

Comparison to Industry Standards

  • The vesting and conversion of Restricted Stock Units (RSUs) is a common form of equity compensation for directors and executives across various industries, aligning their interests with long-term shareholder value. This transaction is consistent with typical compensation practices seen in companies like Quest Diagnostics (DGX) or other large healthcare service providers.

Related Party Transactions

  • The vesting and conversion of Restricted Stock Units for a director is a routine related-party transaction as part of their compensation package.

Stakeholder Impact

  • Shareholders: The conversion of RSUs into common stock results in a minor increase in the number of outstanding shares, which is a routine part of equity compensation plans. This generally aligns the director's interests with shareholders.

Key Dates

DateDescription
02/11/2026Date of transaction: vesting and conversion of 897 Restricted Stock Units into Common Stock.
02/13/2026Date the Statement of Changes in Beneficial Ownership (Form 4) was signed.

Recommendation

hold

This Form 4 reports a standard vesting and conversion of Restricted Stock Units by a director, which is a routine compensation event and does not provide new information to alter an investment thesis for Labcorp Holdings Inc. The transaction itself is neutral for the stock's fundamental valuation.

Keywords

Labcorp, LH, Form 4, insider transaction, beneficial ownership, director, restricted stock units, common stock, equity compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.